Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the Europ

    ... conditioning and 34% and 27% had intermediate-2 and high international prognostic scoring system (IPSS) scores. At time of HSCT, 32% of patients ...

    Research Article last updated 07/18/2016 - 11:22am.

  2. Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional

    ... PURPOSEThe definition of disease-specific prognostic scores plays a fundamental role in the treatment decision-making ... AND METHODSWe applied the recently published Revised International Prognostic Scoring System (IPSS-R) to 380 patients with MDS, ...

    Research Article last updated 08/07/2013 - 9:18am.

  3. Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index

    ... clinical outcome. For improved risk stratification, the International Prognostic Scoring System (IPSS) has recently been revised (IPSS-R). This ...

    Research Article last updated 01/20/2015 - 1:12pm.

  4. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... clinical and biological activity in patients with International Prognostic Scoring System (IPSS) lower-risk (low- and intermediate-1-risk) ...

    Research Article last updated 06/23/2016 - 10:17am.

  5. Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy

    ... by cytogenetic abnormalities, as previously defined by International Prognostic Scoring System (IPSS) cytogenetics . It has been shown ...

    Research Article last updated 04/08/2015 - 9:59am.

  6. Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysis

    ... World Health Organization, French-American-British, or International Prognostic Scoring System (IPSS) criteria. Outcomes included erythroid ...

    Research Article last updated 06/23/2016 - 9:14am.

  7. The Revised International Prognostic Scoring System (IPSS-R) is not Predictive of Survival in Patients with Secondary Myelodysplastic Syndromes

    ...

    Research Article last updated 05/26/2015 - 11:02am.

  8. Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study

    ... The median age was 73 years, and 79% had revised International Prognostic Scoring System (IPSS-R) risk scores of intermediate or lower. ...

    Research Article last updated 06/07/2016 - 11:03am.

  9. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla

    ... syndromes (MDS). We refined the WHO-classification based Prognostic Scoring System (WPSS) by determining the impact of the newer ... we compared its prognostic power to that of the revised International Prognostic Scoring System (IPSS-R). A population of 5326 ...

    Research Article last updated 03/03/2015 - 12:07pm.

  10. Personalized medicine for MDS

    ... in determining therapy.  Key-Findings: -The International Prognostic Scoring System (IPSS) helps to risk stratify MDS patients into ...

    Research Review last updated 05/02/2016 - 9:44am.